Deriving Competitive Inhibition From Michaelis-Menten Kinetics

Why Competitive Inhibition Depends on Both Concentrations

A competitive inhibitor and a substrate compete for the same enzyme binding site. Raising inhibitor concentration therefore reduces the fraction of enzyme available to bind substrate. Raising substrate concentration can counter that effect by making substrate binding more likely. The resulting reaction velocity depends on both concentrations, not on inhibitor concentration alone.

The derivation below connects this mechanism to Michaelis–Menten kinetics. It gives a specific, testable rate law and clarifies what the model means when it says that inhibition raises the apparent \(K_m\) without changing \(V_{\max}\). The earlier material on mechanistic enzyme-activity states provides the broader PK/PD context; here the focus is the rate law for reversible competition at the enzyme’s active site.

In the competitive mechanism, substrate and inhibitor bind mutually exclusively: the inhibitor binds free enzyme, but not \(ES\). The rate law is derived under initial-rate conditions, so product has not accumulated appreciably and substrate depletion during measurement is negligible. It also assumes that \(ES\) is at steady state, inhibitor binding to free enzyme is at rapid equilibrium, and measured free substrate and inhibitor concentrations are approximately the concentrations used in the calculation. These conditions are most plausible when enzyme is dilute relative to substrate and inhibitor.

Deriving the Competitive-Inhibition Rate Law

For the uninhibited enzyme, the binding and conversion steps are \(E+S\rightleftharpoons ES\rightarrow E+P\). Under the steady-state approximation for \(ES\), its concentration is related to free enzyme and substrate by \([ES]=[E][S]/K_m\). For the inhibitor, rapid equilibrium gives \([EI]=[E][I]/K_i\). Conservation of total enzyme requires that enzyme occur in one of three forms: free, substrate-bound, or inhibitor-bound.

Solving the conservation equation for free enzyme and substituting into \([ES]=[E][S]/K_m\) gives the substrate-bound fraction. The rate is \(v=k_{\mathrm{cat}}[ES]\), so multiplying that fraction by \(k_{\mathrm{cat}}E_T=V_{\max}\) yields the competitive rate law.

Define \(\alpha=1+[I]/K_i\). Then the equation has the same form as the Michaelis–Menten equation, but with an apparent Michaelis constant \(K_{m,\mathrm{app}}=\alpha K_m\). At \([I]=0\), \(\alpha=1\), and the uninhibited equation is recovered. For positive inhibitor concentration, \(\alpha>1\): at a given substrate concentration, more substrate is required to reach a given fraction of \(V_{\max}\). Under the stated model, \(V_{\max}\) is unchanged because sufficiently high substrate can outcompete inhibitor and drive the enzyme toward substrate saturation.

Worked Applications

Assumptions, Diagnostics, and Alternatives

The equation is useful only if its mechanism and measurement conditions are plausible. It treats inhibitor binding as reversible and rapid relative to the rate measurement, and treats inhibitor as binding free enzyme but not the substrate-bound complex. It also assumes a stable enzyme amount during measurement and a velocity that can be represented by the initial-rate model. If substrate or inhibitor is substantially depleted by binding or reaction, the free concentrations may differ from the nominal concentrations; the calculation may then need a mass-balance model rather than direct substitution of nominal concentrations.

A practical diagnostic is to measure rates across several substrate concentrations at more than one inhibitor concentration. Under competitive inhibition, curves should approach the same high-substrate plateau, while the substrate concentration associated with half that plateau increases with inhibitor concentration. Systematic departures—especially different apparent plateaus or an inhibitor effect that does not diminish at high substrate—suggest that the competitive model may not adequately describe the data. They do not, by themselves, identify which alternative mechanism is correct.

The simplest alternative is the uninhibited Michaelis–Menten model, appropriate when inhibitor is absent or has no measurable effect. Another possibility is an empirical inhibition multiplier on velocity. Such a multiplier may be useful as a descriptive approximation over a restricted concentration range, but it does not encode substrate competition and may predict the wrong change in relative inhibition as \([S]\) varies. If the inhibitor can bind the substrate-bound enzyme or alter catalytic capacity, the competitive rate law is not the appropriate mechanistic description; those mechanisms require different models.

A common mistake is to apply a fixed percentage reduction to \(V_{\max}\) and assume that this represents competitive inhibition at every substrate concentration. In this model, the inhibitor changes the denominator through \(\alpha K_m\); it does not multiply \(V_{\max}\) by a constant fraction. The resulting relative reduction therefore depends on \([S]\), as the rate-ratio calculation shows. Another pitfall is to interpret \(K_i\) as the concentration that always halves velocity. \(K_i\) is a binding dissociation constant in the specified mechanism; the velocity also depends on \(K_m\), \([S]\), and \([I]\).

Linear rearrangements of the rate law can help illustrate parameter relationships, but transforming rates changes the error structure and can give disproportionate influence to some observations. For estimation, it is generally preferable to fit the nonlinear equation to the measured velocities and inspect the fit across the full substrate and inhibitor ranges. Check that the fitted parameters are plausible, that predicted and observed rates do not show systematic discrepancies, and that the data include enough concentration variation to distinguish the effects of \(K_m\), \(V_{\max}\), and \(K_i\). A good numerical fit alone cannot establish the binding mechanism.